Bortezomib-Based Regimens Used as Induction in Newly Diagnosed Multiple Myeloma (Ndmm) Patients Eligible for Stem Cell Transplantation (Sct)The Cost-Utility Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.1340
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

Stem Cells International
Cell BiologyMolecular Biology
2012English

Peripheral Neuropathy Induced by Subcutaneous Bortezomib-Based Induction Therapy for Newly Diagnosed Multiple Myeloma

Haematologica
Hematology
2014English

Psy17 - Treatment Regimens for Patients With Newly Diagnosed Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation: A Systematic Literature Review and Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Real-Life Autologous Stem Cell Transplantation and Overall Survival Rates in Newly Diagnosed Multiple Myeloma Patients: An Analysis Based on a German Claims Dataset

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2017English

Bortezomib Plus Dexamethasone Induction Followed by Autologous Stem Cell Transplantation in Multiple Myeloma: A Study From India

Asian Journal of Medical Sciences
2016English

Pcn332 - Real-World Usage of Bortezomib in Combination With Thalidomide and Dexamethasone (Vtd) as Frontline (Fl) Treatment in Stem Cell Transplant (Sct) Eligible Multiple Myeloma (Mm) Patients Across Eu5 Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Stem Cell Mobilization and Autograft Purity With Novel Induction Regimens in Multiple Myeloma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Allogeneic Hematopoietic Cell Transplantation for Consolidation of VGPR or CR for Newly Diagnosed Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy